Melvin Booth

Melvin Booth

Nessuna posizione attualmente
81 anni
Health Technology
Commercial Services
Finance

Profilo

Melvin D.
Booth
held various leadership positions in the pharmaceutical industry, including Chairman of PRA Health Sciences, ERT Operating Co., Prestwick Pharmaceuticals, Mallinckrodt Plc, Canada's Research Based Pharmaceutical Cos., and Pharmaceutical Manufacturers Association of Canada.
He was also President, Chief Operating Officer & Director of Human Genome Sciences, Inc. and President of Syntex Laboratories, Inc. He served as a Director of MedImmune LLC, EMD Millipore Corp., Catalent Pharma Solutions, Inc., and Ventria Bioscience, Inc. Additionally, he was an Advisory Committee Member of Genstar Capital Management LLC and President of BioSpace, Inc. He earned an undergraduate degree from Northwest Missouri State University in 1967.

Precedenti posizioni note di Melvin Booth

SocietàPosizioneFine
MALLINCKRODT PLC Presidente 16/05/2018
Direttore/Membro del Consiglio 01/09/2017
CATALENT, INC. Direttore/Membro del Consiglio 25/08/2017
Presidente 01/05/2016
PRA HEALTH SCIENCES, INC. Presidente 01/01/2013
Vedi nel dettaglio l'esperienza di Melvin Booth

Formazione di Melvin Booth

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

71

Relazioni di 1° grado

23

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private23

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance

Technology Services

Technology Services

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Syntex Laboratories, Inc.

Miscellaneous

Kwik-Way Industries, Inc.

Syntex Dental Products, Inc.

Syntex Pharmaceuticals Ltd.

Health Technology

Pharmaceutical Manufacturers Association of Canada

Health Technology

  1. Mercati
  2. Insiders
  3. Melvin Booth
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA